Patents by Inventor Jannik DONNER

Jannik DONNER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Carolacton and derivatives thereof for use in the treatment of cell proliferation disorders
    Patent number: 11357752
    Abstract: Chemical compounds are provided that are useful in the treatment of diseases associated with an activity of a 5,10-methylenyltetrahydrofolate cyclohydrolase/5,10-methylene tetrahydrofolate dehydrogenase enzyme in pathological eukaryotic cells. In particular, compounds that exhibit inhibitory activity upon 5,10-methylenyltetrahydrofolate cyclohydrolase/5,10-methylene tetrahydrofolate dehydrogenase enzymes and their use in the treatment of cancer and/or parasitic diseases are provided.
    Type: Grant
    Filed: June 1, 2018
    Date of Patent: June 14, 2022
    Assignee: HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH
    Inventors: Chengzhang Fu, Rolf Muller, Jannik Donner, Michael Reck, Irene Wagner-Dobler, Andreas Kirschning, Jonas Ammermann
  • CAROLACTON AND DERIVATIVES THEREOF FOR USE IN THE TREATMENT OF CELL PROLIFERATION DISORDERS
    Publication number: 20210186926
    Abstract: Chemical compounds are provided that are useful in the treatment of diseases associated with an activity of a 5,10-methylenyltetrahydrofolate cyclohydrolase/5,10-methylene tetrahydrofolate dehydrogenase enzyme in pathological eukaryotic cells.
    Type: Application
    Filed: June 1, 2018
    Publication date: June 24, 2021
    Applicant: Helmholtz-Zentrum für Infektionsforschung GmbH
    Inventors: Chengzhang FU, Rolf MULLER, Jannik DONNER, Michael RECK, Irene WAGNER-DOBLER, Andreas KIRSCHNING, Jonas AMMERRMANN